Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Monoammonium Glycyrrhizinate has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
This is the interaction that matters most for the ingredient and it works against potassium status. Regular intake over weeks drives potassium out in the urine, and adding potassium alongside does not remove the enzyme inhibition causing it. The effect scales with dose and duration rather than appearing after a single serving.
Sodium retention raises blood pressure, and a high dietary sodium load pushes in the same direction through the same route. The two stack rather than cancel. Several countries set daily glycyrrhizin intake ceilings for this reason.
A product carrying both the salt and whole licorice root delivers one active from two label entries, and total daily glycyrrhizin is what governs the electrolyte effect. Formulators sometimes double up without noticing. Deglycyrrhizinated licorice is the exception because the active has been stripped out.
Glycyrrhizin preparations are used clinically in China and Japan in the setting of elevated liver enzymes, and silymarin occupies a similar role in European practice. Both have antioxidant and membrane-stabilising mechanisms described in laboratory work. Head to head data on the pair against either alone is thin, so read the combination as convention with mechanistic support.
The perinatal cow study reported improvements in oxidative stress markers with monoammonium glycyrrhizinate, which is a marker-level finding in a non-human species. Glutathione operates in the same broad antioxidant network. The pairing is mechanistically coherent and untested in people.
Lipid and aqueous phase antioxidants cover different compartments and do not substitute for one another. Combining them is standard antioxidant formulation. This says nothing about clinical outcomes for either ingredient.
Marshmallow supplies viscous mucilage that physically coats mucosal surfaces, which is unrelated to what glycyrrhizin does. The pairing is old herbal practice. No controlled work has tested the combination.
The two co-occur in gastric and throat formulas across European herbal practice. Chamomile contributes apigenin and related flavonoids with their own laboratory literature. The combination has not been studied and any electrolyte considerations for glycyrrhizin still apply.
Glycyrrhizinate salts are added at low levels as sweeteners and bitterness maskers, and they leave a persistent licorice note. Glycine softens that finish and helps hold formulation pH. This is sensory and physical chemistry with no physiological implication.
Nothing specific on file for Monoammonium Glycyrrhizinate. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 2 we read for Monoammonium Glycyrrhizinate. The full linked list is below.
Read this carefully. These are 207 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Monoammonium Glycyrrhizinate is, not how risky it is. A report is not proof Monoammonium Glycyrrhizinate caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.